Sagent Pharmaceuticals Announces The Introduction of Oxaliplatin Injection, USP
September 23, 2014 at 16:05 PM EDT
Sagent Pharmaceuticals, Inc. (Nasdaq: SGNT) today announced the introduction of Oxaliplatin Injection, USP, an antineoplastic agent, now ...